249 related articles for article (PubMed ID: 26489816)
1. A case of hypercalcemia Indications for 1,25-dihydroxyvitamin D prescription.
Malandain D; Roussey G; Leloupp AG; Graveline N; Masson D; Bach-Ngohou K
Ann Biol Clin (Paris); 2015; 73(5):573-80. PubMed ID: 26489816
[TBL] [Abstract][Full Text] [Related]
2. Kidney function and influence of sunlight exposure in patients with impaired 24-hydroxylation of vitamin D due to CYP24A1 mutations.
Figueres ML; Linglart A; Bienaime F; Allain-Launay E; Roussey-Kessler G; Ryckewaert A; Kottler ML; Hourmant M
Am J Kidney Dis; 2015 Jan; 65(1):122-6. PubMed ID: 25446019
[TBL] [Abstract][Full Text] [Related]
3. Idiopathic Infantile Hypercalcemia, Presenting in Adulthood--No Longer Idiopathic Nor Infantile: Two Case Reports and Review.
Tray KA; Laut J; Saidi A
Conn Med; 2015; 79(10):593-7. PubMed ID: 26731879
[TBL] [Abstract][Full Text] [Related]
4. CYP24A1 Mutation in a Girl Infant with Idiopathic Infantile Hypercalcemia.
Madsen JOB; Sauer S; Beck B; Johannesen J
J Clin Res Pediatr Endocrinol; 2018 Mar; 10(1):83-86. PubMed ID: 28874334
[TBL] [Abstract][Full Text] [Related]
5. CYP24A1 Mutations in a Cohort of Hypercalcemic Patients: Evidence for a Recessive Trait.
Molin A; Baudoin R; Kaufmann M; Souberbielle JC; Ryckewaert A; Vantyghem MC; Eckart P; Bacchetta J; Deschenes G; Kesler-Roussey G; Coudray N; Richard N; Wraich M; Bonafiglia Q; Tiulpakov A; Jones G; Kottler ML
J Clin Endocrinol Metab; 2015 Oct; 100(10):E1343-52. PubMed ID: 26214117
[TBL] [Abstract][Full Text] [Related]
6. [Hypercalcemia and inactive mutation of CYP24A1. Case-study and literature review].
Seidowsky A; Villain C; Vilaine E; Baudoin R; Tabarin A; Kottler ML; Cavalier É; Souberbielle JC; Massy ZA
Nephrol Ther; 2017 May; 13(3):146-153. PubMed ID: 28456639
[TBL] [Abstract][Full Text] [Related]
7. Hypercalcemia in Pregnancy Due to CYP24A1 Mutations: Case Report and Review of the Literature.
Pilz S; Theiler-Schwetz V; Pludowski P; Zelzer S; Meinitzer A; Karras SN; Misiorowski W; Zittermann A; März W; Trummer C
Nutrients; 2022 Jun; 14(12):. PubMed ID: 35745247
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment.
Tebben PJ; Singh RJ; Kumar R
Endocr Rev; 2016 Oct; 37(5):521-547. PubMed ID: 27588937
[TBL] [Abstract][Full Text] [Related]
9. [New Mutation of CYP24A1 in a Case of Idiopathic Infantile Hypercalcemia Diagnosed in Adulthood].
Zanchelli F; Giudicissi A; Neri L; Sgarlato V; Bruno PF; Ruggeri M; Signorotti S; Vetrano D; Buscaroli A
G Ital Nefrol; 2023 Dec; 40(6):. PubMed ID: 38156538
[TBL] [Abstract][Full Text] [Related]
10. Differential diagnosis of vitamin D-related hypercalcemia using serum vitamin D metabolite profiling.
Kaufmann M; Schlingmann KP; Berezin L; Molin A; Sheftel J; Vig M; Gallagher JC; Nagata A; Masoud SS; Sakamoto R; Nagasawa K; Uesugi M; Kottler ML; Konrad M; Jones G
J Bone Miner Res; 2021 Jul; 36(7):1340-1350. PubMed ID: 33856702
[TBL] [Abstract][Full Text] [Related]
11. CYP3A4 Induction by Rifampin: An Alternative Pathway for Vitamin D Inactivation in Patients With CYP24A1 Mutations.
Hawkes CP; Li D; Hakonarson H; Meyers KE; Thummel KE; Levine MA
J Clin Endocrinol Metab; 2017 May; 102(5):1440-1446. PubMed ID: 28324001
[TBL] [Abstract][Full Text] [Related]
12. Maternal Hypercalcemia Due to Failure of 1,25-Dihydroxyvitamin-D3 Catabolism in a Patient With CYP24A1 Mutations.
Shah AD; Hsiao EC; O'Donnell B; Salmeen K; Nussbaum R; Krebs M; Baumgartner-Parzer S; Kaufmann M; Jones G; Bikle DD; Wang Y; Mathew AS; Shoback D; Block-Kurbisch I
J Clin Endocrinol Metab; 2015 Aug; 100(8):2832-6. PubMed ID: 26097993
[TBL] [Abstract][Full Text] [Related]
13. CYP24A1 loss of function: Clinical phenotype of monoallelic and biallelic mutations.
Carpenter TO
J Steroid Biochem Mol Biol; 2017 Oct; 173():337-340. PubMed ID: 28093352
[TBL] [Abstract][Full Text] [Related]
14. Mutations in CYP24A1 and idiopathic infantile hypercalcemia.
Schlingmann KP; Kaufmann M; Weber S; Irwin A; Goos C; John U; Misselwitz J; Klaus G; Kuwertz-Bröking E; Fehrenbach H; Wingen AM; Güran T; Hoenderop JG; Bindels RJ; Prosser DE; Jones G; Konrad M
N Engl J Med; 2011 Aug; 365(5):410-21. PubMed ID: 21675912
[TBL] [Abstract][Full Text] [Related]
15. Biallelic mutations in CYP24A1 or SLC34A1 as a cause of infantile idiopathic hypercalcemia (IIH) with vitamin D hypersensitivity: molecular study of 11 historical IIH cases.
Pronicka E; Ciara E; Halat P; Janiec A; Wójcik M; Rowińska E; Rokicki D; Płudowski P; Wojciechowska E; Wierzbicka A; Książyk JB; Jacoszek A; Konrad M; Schlingmann KP; Litwin M
J Appl Genet; 2017 Aug; 58(3):349-353. PubMed ID: 28470390
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D-dependent Hypercalcemia.
Schlingmann KP
Endocrinol Metab Clin North Am; 2021 Dec; 50(4):729-742. PubMed ID: 34774244
[TBL] [Abstract][Full Text] [Related]
17. Discordant Clinical Course of Vitamin-D-Hydroxylase (CYP24A1) Associated Hypercalcemia in Two Adult Brothers With Nephrocalcinosis.
Jobst-Schwan T; Pannes A; Schlingmann KP; Eckardt KU; Beck BB; Wiesener MS
Kidney Blood Press Res; 2015; 40(5):443-51. PubMed ID: 26304832
[TBL] [Abstract][Full Text] [Related]
18. Analysis of vitamin D
Kowalska E; Rola R; Wójcik M; Łaszcz N; Płudowski P; Wierzbicka A; Janiec A; Książyk J; Halat P; Ciara E; Obrycki Ł; Pronicka E; Litwin M
J Steroid Biochem Mol Biol; 2021 Apr; 208():105824. PubMed ID: 33516786
[TBL] [Abstract][Full Text] [Related]
19. Severe hypercalcemic crisis in an infant with idiopathic infantile hypercalcemia caused by mutation in CYP24A1 gene.
Fencl F; Bláhová K; Schlingmann KP; Konrad M; Seeman T
Eur J Pediatr; 2013 Jan; 172(1):45-9. PubMed ID: 23001465
[TBL] [Abstract][Full Text] [Related]
20. [Overdose or hypersensitivity to vitamin D?].
Hmami F; Oulmaati A; Amarti A; Kottler ML; Bouharrou A
Arch Pediatr; 2014 Oct; 21(10):1115-9. PubMed ID: 25129320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
